Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City: Woburn
State: Massachusetts
Zip:
Country: United States
Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics. The company licensed products focus on the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Biofrontera was founded in 2015 and is headquartered in Woburn, MA.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/29/2021
IPO Valuation:
$66M
Ticker Symbol:
BFRI
IPO Price:
$5/share
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2022 | Post-IPO Equity | $9.4M | 11/2022 | Post-IPO Equity | $3.7M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|